Impact of Genetic Testing Among Patients With Familial Hypercholesterolemia on Adverse Cardiovascular Events　― The Hokuriku-Plus Familial Hypercholesterolemia Registry Study ―

Key Points

• This research aims to clarify how genetic testing affects major cardiovascular events in patients with heterozygous familial hypercholesterolemia.
• Utilized data from the Hokuriku-plus FH Registry
• Focus on patients with heterozygous familial hypercholesterolemia
• Tracked major adverse cardiovascular events (MACE)
• Inclusion of genetic testing is linked to lower rates of MACE
• Patients with genetic testing showed improved cardiovascular outcomes
• The impact of genetic testing varies based on individual patient profiles